UNSPSC 51282953: Enoxacin

This classification denotes an anti-infective agent with the molecular formula C15H17FN4O3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 325OGW249P, chemically known as 1,8-naphthyridine-3-carboxylic acid, 6-fluoro-1,4-dihydro- 4-oxo-7-piperazinyl but more generally known as enoxacin, which bears US NIH Compound Identifier 3229. European Medicines Agency schedules Enoxacin in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06540MIG.

UNSPSC 51282953 Enoxacin, a Commodity code, nominally describes a specific fluoroquinolone antibiotic; however, recent state and local procurement activity under this code shows little direct purchasing of enoxacin itself. Instead, the tagged opportunities reflect broader pharmaceutical procurement — a piggyback warehouse supply contract awarded by the Illinois Department of Public Health for doxycycline hyclate and ciprofloxacin tablets, and a Seminole County, Florida IFB for naloxone and drug deactivation systems. State and local health departments and county public-health agencies are the primary issuers, but the actual commodities being procured diverge substantially from the code's nominal scope, suggesting either misclassification in the procurement system or that the code functions as a catch-all for urgent pharmaceutical acquisitions outside established categories.

The Illinois Department of Public Health awarded a $2,999,999.11 piggyback pharmaceutical warehouse contract to Chartwell Rx LLC on August 28, 2026, through the MMCAP Infuse consortium, supplying doxycycline hyclate 100mg and ciprofloxacin hydrochloride 500mg tablets over a 12-month initial term with two renewal options; Seminole County, Florida posted an IFB on June 30, 2026, for 1,900 units of naloxone and 800 safe drug deactivation systems annually, with quarterly deliveries to the county community health building and a two-year initial term plus one-year renewal option. Activity is concentrated in Florida and Illinois, with both opportunities reflecting emergency-response and community-health inventory needs. Vendors pursuing this code should note that recent activity centers on multi-unit pharmaceutical supply and health-system logistics rather than single-drug procurement, and that cooperative purchasing vehicles such as MMCAP Infuse are common procurement pathways for state health departments.